SWM
RARE icon

SHP Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

SHP Wealth Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26K Buy
+60
New +$1.35K ﹤0.01% 1405

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SHP Wealth Management's RARE Position: Q1 2026 in Review

SHP Wealth Management opened a new position in Ultragenyx Pharmaceutical (RARE) in Q1 2026: 60 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #1405 among its holdings.

296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • SHP Wealth Management held 60 shares of Ultragenyx Pharmaceutical worth $1.26K as of Q1 2026.
  • Ultragenyx Pharmaceutical was a new SHP Wealth Management position in Q1 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1405 holding.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.